JP2022553378A5 - - Google Patents
Info
- Publication number
- JP2022553378A5 JP2022553378A5 JP2022523912A JP2022523912A JP2022553378A5 JP 2022553378 A5 JP2022553378 A5 JP 2022553378A5 JP 2022523912 A JP2022523912 A JP 2022523912A JP 2022523912 A JP2022523912 A JP 2022523912A JP 2022553378 A5 JP2022553378 A5 JP 2022553378A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- hvr
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962925704P | 2019-10-24 | 2019-10-24 | |
| US62/925,704 | 2019-10-24 | ||
| PCT/US2020/018405 WO2020168271A1 (en) | 2019-02-15 | 2020-02-14 | Methods and compositions for treating mast cell gastritis, mast cell esophagitis, mast cell enteritis, mast cell duodenitis, and/or mast cell gastroenteritis |
| USPCT/US2020/018405 | 2020-02-14 | ||
| US202063067743P | 2020-08-19 | 2020-08-19 | |
| US63/067,743 | 2020-08-19 | ||
| PCT/US2020/057174 WO2021081411A1 (en) | 2019-10-24 | 2020-10-23 | Methods and compositions for treating irritable bowel syndrome and functional dyspepsia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553378A JP2022553378A (ja) | 2022-12-22 |
| JP2022553378A5 true JP2022553378A5 (https=) | 2023-10-30 |
Family
ID=75619380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523912A Pending JP2022553378A (ja) | 2019-10-24 | 2020-10-23 | 過敏性腸症候群および機能性ディスペプシアを処置するための方法および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220380460A1 (https=) |
| EP (1) | EP4048698A4 (https=) |
| JP (1) | JP2022553378A (https=) |
| CN (1) | CN114829406A (https=) |
| WO (1) | WO2021081411A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL270304B2 (en) * | 2017-05-05 | 2024-07-01 | Allakos Inc | Methods and preparations for the treatment of inflammatory disorders in the digestive system |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ720769A (en) * | 2013-12-09 | 2022-10-28 | Allakos Inc | Anti-siglec-8 antibodies and methods of use thereof |
| IL270304B2 (en) * | 2017-05-05 | 2024-07-01 | Allakos Inc | Methods and preparations for the treatment of inflammatory disorders in the digestive system |
| AU2020223365A1 (en) * | 2019-02-15 | 2021-08-26 | Allakos Inc. | Methods and compositions for treating mast cell gastritis, mast cell esophagitis, mast cell enteritis, mast cell duodenitis, and/or mast cell gastroenteritis |
| KR20220044203A (ko) * | 2019-08-02 | 2022-04-06 | 알라코스 인크. | 항-siglec-8 항체 및 코르티코스테로이드를 투여하는 방법 |
-
2020
- 2020-10-23 WO PCT/US2020/057174 patent/WO2021081411A1/en not_active Ceased
- 2020-10-23 CN CN202080087957.8A patent/CN114829406A/zh active Pending
- 2020-10-23 EP EP20880322.1A patent/EP4048698A4/en not_active Withdrawn
- 2020-10-23 JP JP2022523912A patent/JP2022553378A/ja active Pending
- 2020-10-23 US US17/770,439 patent/US20220380460A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2914203C (en) | Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r inhibitor | |
| JP2020503260A5 (https=) | ||
| JP2023517236A5 (https=) | ||
| JP2023524149A5 (https=) | ||
| JP2022542472A5 (https=) | ||
| JP2023542289A5 (https=) | ||
| JP2022520105A5 (https=) | ||
| JP2024534602A5 (https=) | ||
| JP2022532356A5 (https=) | ||
| JP2023548064A5 (https=) | ||
| JP2022547577A5 (https=) | ||
| JP2024069230A5 (https=) | ||
| JP2023520771A5 (https=) | ||
| JP2018533569A5 (https=) | ||
| JP2022529929A5 (https=) | ||
| JP2022500382A5 (https=) | ||
| JP2022553378A5 (https=) | ||
| JP2021523117A5 (https=) | ||
| JP2024540435A5 (https=) | ||
| CA3239667A1 (en) | Interleukin 5 binding protein dosage regimen for use in treating polyangiitis, hypereosinophilic syndrome, hypereosinophilic syndrome chronic rhinosinusitis with nasal polyps (crswnp), or chronic rhinosinusitis without nasal polyps (crssnp | |
| JP2022513029A5 (https=) | ||
| CN112955148B (zh) | Cdk4/6抑制剂联合免疫治疗在制备治疗淋巴瘤的药物中的用途 | |
| JP2023506779A5 (https=) | ||
| JP2022520572A5 (https=) | ||
| JP2022549218A5 (https=) |